NEURO62

Presentation information

Oral Session

[O-26] Oral Session 26 Dementia3

Fri. May 21, 2021 9:45 AM - 11:15 AM Room 03 (ICC Kyoto 1F Annex Hall 2)

Chair:Head Quarters Office

[O-26-2] Efficacy of novel marker, MR-pro ADM, in mild cognitive impairment with intracranial microbleeds

Nagato Kuriyama1, Teruhide Koyama1, Etsuko Ozaki1, Satoshi Saito4, Satoshi Hosoki4, Masafumi Ihara4, Daisuke Matsui1, Isao Watanabe1, Masaki Kondo2, Toshiki Mizuno2, Yoshinori Marunaka5, Akihiro Takada5, Kentaro Akazawa3, Kei Yamada3, Satomi Tomida1, Reo Nagamitsu1, Yukiko Nukaya1, Ritei Uehara1 (1.Departments of Epidemiology for Community Health and Medicine, Research Institute for Neurological diseases and Geriatrics, Kyoto Prefectural University of Medicine, Kyoto, Japan, 2.Department of Neurology, Kyoto Prefectural University of Medicine, Kyoto, Japan, 3.Department of Radiology, Kyoto Prefectural University of Medicine, Kyoto, Japan, 4.Department of Stroke and Cerebrovascular Diseases, Division of Neurology, National Cerebral and Cardiovascular Center, Osaka, Japan, 5.Kyoto Industrial Health Association, Kyoto, Japan)

Abstract password authentication.
Password is written on a pocket program and name badge.

Password